These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17214582)

  • 1. NF-kappaB and rheumatic diseases.
    Okamoto T
    Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):359-72. PubMed ID: 17214582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-kappa B signaling and carcinogenesis.
    Okamoto T; Sanda T; Asamitsu K
    Curr Pharm Des; 2007; 13(5):447-62. PubMed ID: 17348842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis.
    Brown KD; Claudio E; Siebenlist U
    Arthritis Res Ther; 2008; 10(4):212. PubMed ID: 18771589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of NF-kappaB signaling by fenofibrate, a peroxisome proliferator-activated receptor-alpha ligand, presents a therapeutic strategy for rheumatoid arthritis.
    Okamoto H; Iwamoto T; Kotake S; Momohara S; Yamanaka H; Kamatani N
    Clin Exp Rheumatol; 2005; 23(3):323-30. PubMed ID: 15971419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic targeting of B lymphocyte stimulator (BLyS) in the rheumatic diseases.
    Stohl W
    Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):351-8. PubMed ID: 17214581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of NF-kappaB signaling by fasudil as a potential therapeutic strategy for rheumatoid arthritis.
    Okamoto H; Yoshio T; Kaneko H; Yamanaka H
    Arthritis Rheum; 2010 Jan; 62(1):82-92. PubMed ID: 20039418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Pharmacological Mechanisms and Therapeutic Activities of Hydroxychloroquine in Rheumatic and Related Diseases.
    Hu C; Lu L; Wan JP; Wen C
    Curr Med Chem; 2017; 24(20):2241-2249. PubMed ID: 28302011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity of NF-κB signalling and inflammatory heterogeneity in Rheumatic Autoimmune Disease.
    Manou-Stathopoulou S; Lewis MJ
    Semin Immunol; 2021 Dec; 58():101649. PubMed ID: 36064646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective regulation of IKKβ/NF-κB pathway involved in proliferation inhibition of HFLS-RA cells induced by 1,7-dihydroxyl-3,4-dimethoxylxanthone.
    Ji CL; Jiang H; Tao MQ; Wu WT; Jiang J; Zuo J
    Kaohsiung J Med Sci; 2017 Oct; 33(10):486-495. PubMed ID: 28962819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Truncated Variant of ASCC1, a Novel Inhibitor of NF-κB, Is Associated with Disease Severity in Patients with Rheumatoid Arthritis.
    Torices S; Alvarez-Rodríguez L; Grande L; Varela I; Muñoz P; Pascual D; Balsa A; López-Hoyos M; Martinez-Taboada V; Fernández-Luna JL
    J Immunol; 2015 Dec; 195(11):5415-20. PubMed ID: 26503956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory activities of Chinese herbal medicine sinomenine and Liang Miao San on tumor necrosis factor-α-activated human fibroblast-like synoviocytes in rheumatoid arthritis.
    Chen DP; Wong CK; Leung PC; Fung KP; Lau CB; Lau CP; Li EK; Tam LS; Lam CW
    J Ethnopharmacol; 2011 Sep; 137(1):457-68. PubMed ID: 21679760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular signaling pathways as a target for the treatment of rheumatoid arthritis.
    Kumar S; Blake SM; Emery JG
    Curr Opin Pharmacol; 2001 Jun; 1(3):307-13. PubMed ID: 11712756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis.
    Roman-Blas JA; Jimenez SA
    Osteoarthritis Cartilage; 2006 Sep; 14(9):839-48. PubMed ID: 16730463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [NF-kappaB as a therapeutic target of rheumatoid arthritis].
    Okamoto T; Tsuchiya A
    Nihon Rinsho Meneki Gakkai Kaishi; 2007 Oct; 30(5):383-9. PubMed ID: 17984578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rheumatic diseases in pregnancy].
    Märker-Hermann E; Bauer H; Gromnica-Ihle E
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2410-4. PubMed ID: 18988134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products.
    Ahn KS; Sethi G; Aggarwal BB
    Mol Pharmacol; 2007 Jan; 71(1):209-19. PubMed ID: 17028156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel inhibitor of I-kappaB kinase beta ameliorates experimental arthritis through downregulation of proinflammatory cytokines in arthritic joints.
    Tanaka S; Toki T; Yokoyama M; Shimizu H; Yamasaki T; Yoneda Y; Muro F; Yasukochi T; Iimura S; Morishita K
    Biol Pharm Bull; 2014; 37(1):87-95. PubMed ID: 24389485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-canonical NF-κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde?
    Noort AR; Tak PP; Tas SW
    Arthritis Res Ther; 2015 Jan; 17(1):15. PubMed ID: 25774937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear factor kappaB (NF-kappaB) pathway as a therapeutic target in rheumatoid arthritis.
    Jue DM; Jeon KI; Jeong JY
    J Korean Med Sci; 1999 Jun; 14(3):231-8. PubMed ID: 10402163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,25(OH)
    Tian R; Li X; Li Y; Wang K; Wang C; Yang P
    Biomed Pharmacother; 2018 Oct; 106():149-155. PubMed ID: 29957465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.